943750-38-7 Usage
General Description
2-(4-Bromo-phenyl)-pyrrolidine-1-carboxylic acid tert-butyl ester is a chemical compound used in organic synthesis and pharmaceutical research. It is a tert-butyl ester derivative of 2-(4-bromo-phenyl)-pyrrolidine-1-carboxylic acid, which is a potential cholinesterase inhibitor. This chemical has been studied for its potential use in the treatment of Alzheimer's disease and other neurodegenerative disorders, as it may have the ability to enhance cognitive function. Additionally, it has been investigated for its role in the synthesis of various pharmaceutical compounds, demonstrating its versatility in drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 943750-38-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,3,7,5 and 0 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 943750-38:
(8*9)+(7*4)+(6*3)+(5*7)+(4*5)+(3*0)+(2*3)+(1*8)=187
187 % 10 = 7
So 943750-38-7 is a valid CAS Registry Number.
943750-38-7Relevant articles and documents
STRAD-BINDING AGENTS AND USES THEREOF
-
Paragraph 1171-1173, (2021/08/06)
Disclosed herein, inter alia, are compounds for binding STRAD pseudokinase and uses thereof.
A soluble iron(ii)-phthalocyanine-catalyzed intramolecular C(sp3)-H amination with alkyl azides
Che, Chi-Ming,Fan, Jianqiang,Kang, Fangyuan,Liu, Yungen,Wu, Liangliang,You, Tingjie,Zeng, Si-Hao
, p. 10711 - 10714 (2021/10/20)
Herein, we describe a soluble iron(ii)-phthalocyanine, [FeII(tBu4Pc)(py)2] (Pc = phthalocyaninato(2-)), as an effective catalyst in intramolecular C(sp3)-H bond amination, with alkyl azides as the nit
IMIDAZO[1,2-C]PYRIMIDINE DERIVATIVES AS PRC2 INHIBITORS FOR TREATING CANCER
-
Paragraph 0333, (2020/12/29)
Disclosed are compounds that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, disclosed are compounds of Formula (I) and pharmaceutical compositions thereof, and methods of using the compounds and pharmaceutical compositions in, for example, methods of treating cancer.